The average P/S ratio for PCVX's competitors is 50.60, providing a benchmark for relative valuation. Vaxcyte Inc Corp (PCVX) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.